Eye drop trial offers new hope for wet AMD patients
NCT ID NCT06704009
Summary
This study is testing a new eye drop called NT-101 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. Researchers want to see if these drops are safe and if they might help control the disease. The trial involves about 30 participants who will use the eye drops and be monitored for 8 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WET AGE-RELATED MACULAR DEGENERATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Duke Eye Center
Durham, North Carolina, 27705, United States
-
Elman Retina Group
Rosedale, Maryland, 21237, United States
-
Erie Retina Research
Erie, Pennsylvania, 16505, United States
-
Texas Retina Associates
Dallas, Texas, 75231, United States
Conditions
Explore the condition pages connected to this study.